DOA Test Cup
  • Packaging Details: 1 test/pouch, 10 tests/box
  • Certification: ISO13485, CE

Rapid DOA Test Cup is an immunochromatography based one step in vitro test. It is designed for qualitative determination of drug substances in human urine specimens. This assay may be used in the point of care setting. Below is a list of cut-off concentrations for each drug.

Amphetamine 1000 ng/ml of d-amphetamine
Barbiturate 300 ng/ml of secobarbital
Benzodiazepine 300 ng/ml of oxazepam
Buprenorphine 10 ng/ml of Buprenorphine-3-β-d-glucoronide
Cocaine 300 ng/ml of benzoylecgonine
EDDP 100 ng/ml of EDDP
Ketamine 1000 ng/ml of Ketamine
Methadone 300 ng/ml of methadone
Methamphetamine ( includes Ecstasy) 1000 ng/ml of (+)methamphetamine
MDMA (Ecstasy specific) 500 ng/ml of MDMA
Opiate 300 ng/ml of morphine
Opiate II 2000 ng/ml of morphine
Oxycodone 100 ng/ml of oxycodone
Phencyclidine 25 ng/ml of phencyclidine
Cannabinoid (THC) 50 ng/ml of 11-nor-△9-THC-9-COOH
Propoxyphene 300 ng/ml of Norpropoxyphene
Tramadol 200 ng/ml of Tramadol
Tricyclic antidepressant (TCA) 1000 ng/ml of Nortriptyline

This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. The optional built-in Adulteration Test is for validation of urine specimen’s integrity and must not be used for In Vitro diagnostic use.

Cat. No. Product Name Specimen Format Sensitivity Read Time
1L27P3 DOA Panel Test Cup, up to 14 drugs, Split type Urine Cup Variable 5 mins
1L27K3 DOA Panel Test Cup, up to 14 drugs, On-site type Urine Cup Variable 5 mins